摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,5,6-4四甲基对苯二甲酸 | 14458-05-0

中文名称
2,3,5,6-4四甲基对苯二甲酸
中文别名
四甲基对苯二甲酸
英文名称
2,3,5,6-tetramethylterephthalic acid
英文别名
2,3,5,6-tetramethyl-1,4-benzenedicarboxylic acid;tetramethylterephthalic acid
2,3,5,6-4四甲基对苯二甲酸化学式
CAS
14458-05-0
化学式
C12H14O4
mdl
MFCD00020290
分子量
222.241
InChiKey
NEOZDUDLYDUOTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    402.6±33.0 °C(Predicted)
  • 密度:
    1.237±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2917399090
  • 储存条件:
    存储条件:2-8℃,请保持干燥。

SDS

SDS:ba7f33f3630fedd4838cc7e29dd03aa9
查看

制备方法与用途

应用

2,3,5,6-4 四甲基对苯二甲酸是一种羧酸类有机物,主要用于有机合成中间体。

上下游信息

反应信息

点击查看最新优质反应信息

文献信息

  • Compound having silsesquioxane skeleton and its polymer
    申请人:Inagaki Jyun-ichi
    公开号:US20050009982A1
    公开(公告)日:2005-01-13
    The present invention relates to a compound represented by Formula (1) and a polymer obtained using the compound: wherein R 1 is phenyl which may have substituents, Q 1 is hydrogen, halogen, alkyl having 1 to 10 carbon atoms, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl or phenyl in which optional hydrogen may be replaced by halogen or alkyl having 1 to 5 carbon atoms, and Q 2 is a group represented by Formula (2) wherein the code < represents a bonding point with silicon, l, m, n and p are independently 0, 1, 2 or 3, A 1 to A 4 are independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, a condensed ring group having 6 to 10 carbon atoms which is a divalent group, or 1,4-phenylene, Z 0 to Z 3 are independently a single bond, —CH═CR—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms, and Z 4 is a single bond, —CH═CH—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms. And Y 1 in Formula (1) is the group defined in Claim 1.
    本发明涉及一种由式(1)表示的化合物和使用该化合物获得的聚合物:其中R1是苯基,可能具有取代基;Q1是氢、卤素、具有1至10个碳原子的烷基、环丙基、环丁基、环戊基、环己基、环己烯基或苯基,其中可选的氢原子可被卤素或具有1至5个碳原子的烷基取代;Q2是由式(2)表示的基团,其中代码<表示与硅的连接点,l、m、n和p独立地为0、1、2或3,A1至A4独立地为单键、1,4-环己亚基、1,4-环己烯亚基、具有6至10个碳原子的缩合环基团,为二价基团,或1,4-苯亚基,Z0至Z3独立地为单键、—CH═CR—、—C≡C—、—COO—、—OCO—或具有1至20个碳原子的烷基,Z4为单键、—CH═CH—、—C≡C—、—COO—、—OCO—或具有1至20个碳原子的烷基。式(1)中的Y1是权利要求1中定义的基团。
  • Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
    申请人:Syntex Inc.
    公开号:US05055451A1
    公开(公告)日:1991-10-08
    Thiol protease inhibitors are disclosed having the formula: ##STR1## or an optical isomer thereof, or a pharmaceutically acceptable salt thereof, wherein: n is 0 or 1; m is 0, 1 or 2; X is H or an N-protecting group; each Y is independently an optionally protected .alpha.-amino acid residue; R is an optionally protected .alpha.-amino acid side chain that is H or CH.sub.3 or that is bonded to the .alpha.-carbon atom to which it is attached by a methylene, methine or phenyl radical; and R' is optionally substituted aryl.
    巯基蛋白酶抑制剂的结构式为:##STR1##或其光学异构体,或其药学上可接受的盐,其中:n为0或1;m为0、1或2;X为H或N-保护基;每个Y独立地是一个可选择保护的α-氨基酸残基;R是一个可选择保护的α-氨基酸侧链,可以是H或CH.sub.3,或者与其连接的α-碳原子通过亚甲基、亚烯基或苯基连接;R'是可选择取代的芳基。
  • ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES
    申请人:Horcajada-Cortes Patricia
    公开号:US20100209354A1
    公开(公告)日:2010-08-19
    The invention relates to nanoparticles made from organometallic hybrid materials made from iron carboxylates, used for example as contrast agents. The particles can also be used for the encapsulation and vectoring of molecules of interest such as active3 pharmaceutical agents, cosmetically interesting compounds and markers. Apart from the intrinsic properties thereof for imaging, said nanoparticles give good results in terms of capacity for loading with medicaments and in biocompatibility.
    该发明涉及由铁羧酸盐制成的有机金属混合材料制成的纳米颗粒,例如用作对比剂。这些颗粒还可用于封装和导向感兴趣的分子,如活性药物、具有化妆品特性的化合物和标记物。除了其成像的固有特性外,这些纳米颗粒在药物载荷能力和生物相容性方面也表现出良好的结果。
  • REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS
    申请人:Serre Christian
    公开号:US20110172412A1
    公开(公告)日:2011-07-14
    The present invention relates to reducible porous crystalline solids, constituted of a metal-organic framework (MOF), for the separation of mixtures of molecules having different unsaturation degrees and/or a different number of unsaturations with a selectivity that can be adjusted by controlling the reduction of the MOF. The MOF solids of the present invention, after reduction, have a strong affinity for molecules containing at least one unsaturation. They can be used in various separation processes, especially those relating to hydrocarbons.
    本发明涉及可还原的多孔晶体固体,由金属有机框架(MOF)构成,用于分离具有不同不饱和度和/或不同不饱和度数量的分子混合物,并且可以通过控制MOF的还原来调节选择性。本发明的MOF固体在还原后对至少含有一个不饱和度的分子具有很强的亲和力。它们可以用于各种分离过程,特别是与烃有关的过程。
  • SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE
    申请人:Horcajada-Cortes Patricia
    公开号:US20100226991A1
    公开(公告)日:2010-09-09
    The invention relates to solid organometallic hybrids with modified surface. Said solid may be used for example for the encapsulation and vectoring of molecules of interest such as active pharmaceutical agents, compounds of interest in cosmetics and markers, for example, contrast agents. Said solids show good results in terms of loading capacity in medicament agents and in biocompatibility.
    该发明涉及具有改性表面的固体有机金属杂化物。所述固体可以用于例如封装和载体化感兴趣的分子,如活性药物剂、化妆品中感兴趣的化合物和标记物,例如对比剂。所述固体在药物剂的装载能力和生物相容性方面表现出良好的结果。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐